Distribution ofLewisandSecretorpolymorphisms and corresponding CA19-9 antigen expression in a Chinese population-Reference-Cited by-同舟云学术

Distribution ofLewisandSecretorpolymorphisms and corresponding CA19-9 antigen expression in a Chinese population

Published:2017-10-04 Issue:11 Volume:7 Page:1660-1671
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Guo Meng¹²³,Luo Guopei¹²³,Lu Renquan⁴,Shi Weizhong⁴,Cheng He¹²³,Lu Yu¹²³,Jin Kaizhou¹²³,Yang Chao¹²³,Wang Zhengshi¹²³,Long Jiang¹²³,Xu Jin¹²³,Ni Quanxing¹²³,Liu Chen¹²³,Yu Xianjun¹²³

Affiliation:

1. Department of Pancreatic Surgery; Fudan University Shanghai Cancer Center; China

2. Department of Oncology; Shanghai Medical College; Fudan University; Shanghai China

3. Pancreatic Cancer Institute; Fudan University; Shanghai China

4. Department of Clinical Laboratory; Fudan University Shanghai Cancer Center; China

Funder

Sino-German Center

Natural Science Foundation of Shanghai

National Natural Science Foundation of China

German science foundation

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Reference36 articles.

1. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis;Wannhoff;J Hepatol,2013

2. Molecular genetic analysis of the human Lewis histo-blood group system;Nishihara;J Biol Chem,1994

3. Molecular behavior of mutant Lewis enzymes in vivo;Nishihara;Glycobiology,1999

4. Lewis histo-blood group system and associated secretory phenotypes;Henry;Vox Sang,1995

5. Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype;Kelly;J Biol Chem,1995

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variation of FUT3 gene in the Han population from Northern China;Transfusion Medicine;2024-07-19

2. Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer;Journal of Clinical Oncology;2024-06-20

3. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer;Familial Cancer;2024-04-15

4. Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer;International Journal of Surgery;2024-03-28

5. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present;Biomolecules;2024-03-19